Severe oligozoospermia in a young man with chronic myeloid leukemia on long-term treatment with imatinib started before puberty

Fertility and Sterility

Volumn 95, Issue 3, 2011, Pages 1120.e15-1120.e17

  Mariani, Stefania ^a   Basciani, Sabrina ^b   Fabbri, Andrea ^c   Agati, Luciano ^a   Ulisse, Salvatore ^a   Lubrano, Carla ^a   Spera, Giovanni ^a   Gnessi, Lucio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

chronic myeloid leukemia; Imatinib; oligozoospermia

Indexed keywords

BCR ABL PROTEIN; BIOLOGICAL MARKER; FOLLITROPIN; GONADOTROPIN; IMATINIB; INHIBIN B; TESTOSTERONE;

ADULT; ARTICLE; BIOCHEMISTRY; BONE DENSITY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DUAL ENERGY X RAY ABSORPTIOMETRY; GYNECOMASTIA; HOMEOSTASIS; HUMAN; LONG TERM CARE; MALE; OLIGOSPERMIA; PRIORITY JOURNAL; PUBERTY; SEMEN ANALYSIS; SEVERE OLIGOZOOSPERMIA; SPERMATOGENESIS;

EID: 79951952200     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.08.060     Document Type: Article

References (19)

1. Deininger M, Buchdunger E, Druker BJ. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005;105: 2640-53. (Pubitemid 40446252)
2. Mackay S, Smith RA. Effects of growth factors on testicular morphogenesis. Int Rev Cytol 2007;260: 113-73. (Pubitemid 46670212)
3. Gambacorti-Passerini C, Tornaghi L, Cavagnini F, Rossi P, Pecori-Giraldi F, Mariani L, et al. Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet 2003;361: 1954-6. (Pubitemid 36694586)
4. Caocci G, Atzeni S, Orrù N, Azzena L, Martorana L, Littera R, et al. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia 2008;22:2127-8.
5. Ballardini P, Margutti G, Aliberti C, Manfredini R. Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma. Clin Drug Investig 2009;29:487-90.
6. Apperley J. CML in pregnancy and childhood. Best Pract Res Clin Haematol 2009;22:455-74.
7. Basciani S, de Luca G, Dolci S, Brama M, Arizzi M, Mariani S, et al. Platelet-derived growth factor receptor beta-subtype regulates proliferation and migration of gonocytes. Endocrinology 2008;149: 6226-35.
8. Nurmio M, Toppari J, Zaman F, Andersson AM, Paranko J, Söder O, et al. Inhibition of tyrosine kinases PDGFR and c-kit by imatinib mesylate interferes with postnatal testicular development in the rat. Int J Androl 2007;30:366-76. (Pubitemid 47254397)
9. Nurmio M, Kallio J, Toppari J, Jahnukainen K. Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis. Reprod Toxicol 2008;25:442-6.
10. Seshadri T, Seymour JF, McArthur GA. Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome. N Engl J Med 2004;351:2134-5. (Pubitemid 39482514)
11. Mariani S, Giona F, Basciani S, Brama M, Gnessi L. Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty. Lancet 2008;372:111-2. (Pubitemid 351958458)
12. Kissel H, Timokhina I, Hardy MP, Rothschild G, Tajima Y, Soares V, et al. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J 2000;19:1312-26. (Pubitemid 30151027)
13. Lamar CA, DeCherney AH. Fertility preservation: state of the science and future research directions. Fertil Steril 2009;91:316-9.
14. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6: 209-18.
15. Wyns C, Curaba M, Vanabelle B, van Langendonckt A, Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update 2010;16:312-28.
16. Nielsen CT, Skakkebaek NE, Richardson DW, Darling JA, Hunter WM, Jørgensen M, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986;62:532-5. (Pubitemid 16138172)
17. Hagenäs I, Jørgensen N, Rechnitzer C, Sommer P, Holm M, Schmiegelow K, et al. Clinical and biochemical correlates of successful semen collection for cryopreservation from 12-18-year-old patients: a single-center study of 86 adolescents. Hum Reprod 2010;25:2031-8.
18. Bahadur G, Ling KL, Hart R, Ralph D, Wafa R, Ashraf A, et al. Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod 2002;17: 3157-61. (Pubitemid 35469267)
19. Andres MM, Wallace WHB. Practical and ethical issues for fertility preservation for children and young people with cancer. Paediatr Child Health 2010;20:135-42.